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 CURRENT
OPINION Small entities with large impact: microcalcifications
and atherosclerotic plaque vulnerability
Joshua D. Hutcheson, Natalia Maldonado, and Elena Aikawa
Purpose of review
Atherosclerotic plaque rupture and subsequent acute events, such as myocardial infarction and stroke,
contribute to the majority of cardiovascular-related deaths. Calcification has emerged as a significant
predictor of cardiovascular morbidity and mortality, challenging previously held notions that calcifications
stabilize atherosclerotic plaques. In this review, we address this discrepancy through recent findings that
not all calcifications are equivalent in determining plaque stability.
Recent findings
The risk associated with calcification is inversely associated with calcification density. As opposed to large
calcifications that potentially stabilize the plaque, biomechanical modeling indicates that small
microcalcifications within the plaque fibrous cap can lead to sufficient stress accumulation to cause plaque
rupture. Microcalcifications appear to derive from matrix vesicles enriched in calcium-binding proteins that
are released by cells within the plaque. Clinical detection of microcalcifications has been hampered by the
lack of imaging resolution required for in-vivo visualization; however, recent studies have demonstrated
promising new techniques to predict the presence of microcalcifications.
Summary
Microcalcifications play a major role in destabilizing atherosclerotic plaques. The identification of critical
characteristics that lead to instability along with new imaging modalities to detect their presence in vivo
may allow early identification and prevention of acute cardiovascular events.
Keywords
microcalcification, plaque rupture, vulnerable atherosclerotic plaque
INTRODUCTION
Clinical studies show that calcium score is an excel-
lent predictor of cardiovascular morbidity and
mortality, and coronary calcification is the most
widely used marker of the advancement of athero-
sclerosis [1,2]; however, the link between calcifica-
tion and plaque rupture is still controversial [3
&].
Moreover, the identification of atheromas prone to
rupture and cause subsequent acute cardiovascular
events, such as myocardial infarction and stroke, is
still challenging.
Formerly, the prevailing view was that the pres-
ence of calcification within atherosclerotic plaques
acted as a biomechanical stabilizer. Indeed, large
calcifications easily detected with coronary com-
puted tomography (CT) do not seem to increase
plaque vulnerability [4]. However, recent studies
indicate an inverse relationship between cardio-
vascular risk and calcification density [5
&&], and
spotty or speckled areas of calcification, that can be
observed in intravascular ultrasound (IVUS) [6]
or optical coherence tomography (OCT) [7] are a
goodindicatorofsusceptibilityofrupture[8]. These
observations provide insights into the role calcifica-
tion may play in the stability of the atherosclerotic
plaque and suggest that it is not only the amount of
vascular calcification, but the morphology, size and
location that affect plaque vulnerability. A recent
biomechanical explanation for the contribution of
low density,spotty calcifications to plaque rupture is
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centeredonthepresenceofsmallmicrocalcifications
thatexistwithinthethin fibrous cap of atheroscler-
otic plaques [3
&,9–11,12
&&].
In this review, we will focus on the biomechan-
ical mechanisms by which microcalcifications con-
tribute to plaque instability with special emphasis
given to the important characteristics of dangerous
microcalcifications.Wewillthendiscussourcurrent
understanding of the formation of microcalcifica-
tions. Finally, we will discuss emerging imaging
techniques that have the potential to identify
dangerous microcalcifications forming within athe-
rosclerotic fibrous caps in order to inform clinical
decisions prior to an acute vascular event.
MICROCALCIFICATIONS AND PLAQUE
RUPTURE
The fibrous cap that overlies the soft necrotic core
characteristic of the fibroatheroma [13] is likely to
rupture depending on its mechanical stability. If
the tissue stress in the cap exceeds a critical peak
circumferential stress (PCS), a vulnerable plaque
will rupture at the location in which the stress is
maximum [14]. Inflammation, metalloproteinases,
macrophage infiltration and cell apoptosis affect
mechanical properties of the tissue and result in
reducedcapthickness,increasedcoresizeandabnor-
maltissuecomposition,allleadingtoincreasedstress
in the fibrous cap of the atheroma [15,16].
SeveralbiomechanicalmodelsrelatePCStotissue
properties, plaque morphology, cap thickness and
necrotic core size, based on the principle that the
biomechanical stability of an atheroma determines
its vulnerability. Numerical studies using initially
two-dimensional [13] and, more recently, three-
dimensional finite element analyses [5
&&] and fluid-
structure interaction models [17] indicate that local
tissue properties significantly modify plaque stabi-
lity.However,thesecriteriaareinsufficienttoexplain
almost 40% of the ruptures, suggesting that other
unforeseen factors may play an important role in
distinguishingalesionpronetorupturefromastable
one.
A plausible link between calcification and
plaque rupture came with the detection of minute
microcalcifications less than 60mm size embedded
right in the fibrous cap of human atheromas [9,18].
The presence of hard inclusions, as microcalcifica-
tions,in a muchsofter hyperelasticlayer, the fibrous
cap,createsamismatchintissuepropertiesandlarge
stress concentrations at the interface between cap
and microcalcifications [14], and can lead to sudden
rupture of the fibrous cap [9]. This stress concen-
tration effect depends mostly on microcalcification
size, alongwithitslocation, composition,shape and
proximity to other microcalcifications [11,19]. As
discussed in the following section, the origin of
these dangerous microcalcifications may be the
aggregation of calcified matrix vesicles [12
&&],
repeatedly found in human atheromas [20–23].
Even though matrix vesicles, approximately
50–300 nm, initially don’t seem to significantly
affect plaque vulnerability (an estimated 35%
increase in PCS [24]), it is the aggregation of matrix
vesicles that form progressively larger micro-
calcifications, eventually reaching a critical size,
5–60mm [11], that can trigger the rupture of the
fibrous cap by increasing local stresses more than
500% [12
&&]. Figure 1 shows how microcalcifica-
tions observed in both mice (Fig. 1a) and human
atheromas (Fig. 1b) have a distinct shape likely due
to aggregation of smaller particles and how their
presence affects the stress distribution in the cap
(Fig. 1c, d).
ORIGIN OF MICROCALCIFICATIONS
The origin of microcalcifications remains largely
unknown; however, recent evidence suggests that
matrix vesicles released by cells within the plaque
may serve as nucleating foci for the formation of
microcalcifications [17,25
&,26
&&,27]. Matrix vesicles
have long been observed in the development of
bone, wherein the vesicles are released by living
resident cells and are enriched in calcium-binding
proteins that serve as initiating sites for nucleation
ofcalciumphosphatecrystals[28–30].Bone-derived
matrix vesicles have also been shown to contain the
enzyme alkaline phosphatase, which converts pyro-
phosphate into free phosphate ions [31,32]. Mineral
has been proposed to form within the matrix
vesicles as calcium sequestered within the vesicle
membrane and the phosphate generated by the
activity of alkaline phosphatase reach sufficient
nucleating concentrations [33]. The resultant
hydroxyapatite mineral thatforms from this process
is then deposited along collagen fibers within the
KEY POINTS
 Calcification is a significant predictor of cardiovascular
morbidity and mortality.
 Microcalcifications in the fibrous cap of atherosclerotic
plaques lead to considerable stress accumulation
destabilizing the plaque.
 Emerging imaging modalities may be used to predict
the presence of microcalcifications before plaque
rupture, potentially identifying patients at risk for
myocardial infarction and stroke.
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developing bone [30]. Vascular calcification has
been proposed to involve similar processes, whereby
pathologic conditions cause calcifying matrix
vesicles to be released from cells within the vascular
wall [25
&]. Studies have indicated that both vascular
smooth muscle cells [17] and macrophages [26
&&]
have the propensity to release calcifying matrix
vesicles, and matrix vesicles have been observed
in calcific regions within human and mouse athe-
romas [20]. Corresponding with the observation
that cholesterol and matrix vesicles colocalize
within atherosclerotic lesions (Fig. 2a), oxidized
forms of cholesterol have been shown to enhance
the calcifying activity of matrix vesicles isolated
from rabbit aortae [34].
In contrast to bone matrix vesicle processes,
in which mineralization is alkaline phosphatase
dependent, in-vitro studies indicate that vascular
calcification may involve both alkaline phosphatase
dependent and independent matrix vesicle-induced
mineralization processes [17,25
&]. When macro-
phages or smooth muscle cells are stimulated with
the addition of phosphate ions, vascular matrix
vesicle mineralization mechanisms appear to be
independent of alkaline phosphatase; smooth
musclecell-derivedmatrixvesicleshavebeenshown
to require the calcium-binding protein annexin A6
for calcification [17], whereas mineralization of
macrophage matrix vesicle calcification appears to
involve a complex of annexin A5 and another
calcium-binding protein, S100A9 [25
&]. When phe-
notypic switching of smooth muscle cells to an
osteogenic phenotype is achieved in vitro using a
common osteogenic milieu, it involves cell differ-
entiation and expression of alkaline phosphatase to
hydrolyze phosphoric acid monoesters into free
phosphate ions [35]. In vivo, osteogenic reprogram-
ming of vascular smooth muscle cells has been
observed [35]; however, as alkaline phosphatase
activity generates free phosphate ions, nonosteo-
genic vesicle populations may serve as additional
calcifying foci.
Using advanced microscopic analyses, a recent
study demonstrated the pervasiveness of calci-
fying spherical particles throughout excised
humancardiovasculartissues[36
&&].Theidentified
spherical structures ranged from the size of danger-
ous microcalcifications (5mm) down to the size of
individual matrix vesicles (100nm). The detailed
progression of mineralization from the nucleating
events within matrix vesicles to the development
of dangerous microcalcifications is still uncertain
because of inadequate techniques to monitor these
processes in vivo. Further, the differences between
large, plaque stabilizing calcifications and danger-
ous microcalcifications remain unknown. Matrix
vesicles may serve as nucleating foci for both
types of calcification with the major difference
being the aggregation and location of the vesicles
(Fig. 2b). Future works focusing on this progression
may give new insight into the controllability of
this process for clinical intervention and early
detection methods that can be used to predict
plaque vulnerability.
FIGURE 1. Transmission electron microscopy and histology-based finite element analyses. (a) Transmission electron
microscopy image of aggregated calcifying matrix vesicles forming microcalcifications in a mouse atheroma. (b) Image of a
microcalcification embedded in a human fibrous cap, obtained from nondecalcified histology, and stained with von Kossa.
(c and d) Stress distribution at the interface of the microcalcifications in a and b, respectively, assuming that they are
embedded in fibrous caps under tension. The numbers indicate the factor by which stress is increased and concentrated at
the poles of the microcalcifications. Reproduced with permission from [12
&&].
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DETECTION OF MICROCALCIFICATIONS
AND CLINICAL IMPLICATIONS
In order for our increased understanding of the
significant contribution of microcalcifications
to atherosclerotic plaque vulnerability to impact
clinical decisions, imaging modalities must first be
developed to identify the presence of dangerous
microcalcifications prior to plaque rupture. The
small size of microcalcifications presents a major
challenge for imaging modalities to detect potential
regions of vulnerability in situ. Calcification is
traditionally imaged using CT, which can give an
accurate measure of overall calcium burden, and
improved risk prediction is possible through the
identification of spotty calcifications with IVUS or
OCT. However, CT lacks the resolution to identify
specific dangerous microcalcifications within arte-
rial walls [37], IVUS requires an invasive catheter-
ization procedure, and standard OCT is limited by
tissue penetration depth. Recent advancements
using PET/CT with 18F-sodium fluoride (18F-NaF),
an established PET tracer for bone formation and
remodeling, may provide new strategies for honing
in on regions of plaque vulnerability [38]. Coronary
uptake of 18F-NaF was found overlaying, adjacent
to and distal from regions of CT identified
calcifications [39]. Additionally, large areas of calci-
fication with no 18F-NaF uptakewere observed. This
suggests that, as with bone, 18F-NaF uptake in the
vasculature is a marker of ongoing calcific remodel-
ing [39]. Large, stable calcifications do not exhibit
18F-NaF uptake, whereas active regions of biominer-
alization accumulate 18F-NaF. The 18F-NaF signals
far away from the CT identified calcific regions may
represent the dangerous microcalcifications that
cannot be detected by traditional imaging modal-
ities[39].Insupportofthishypothesis,aprospective
clinical trial showed high 18F-NaF accumulation in
the culprit coronary plaques in cases of myocardial
infarction and in ruptured carotid artery plaques
[40
&&]. Histological evaluation of these plaques
revealed active calcification processes. These PET/
CT techniques exhibit promise in identifying
particularly vulnerable regions within the vascula-
ture; however, they still do not have the resolution
necessary to identify specific microcalcifications
that may contribute to plaque rupture. One strategy
may be to use PET/CT imaging to identify poten-
tially vulnerable regions followed by more invasive
catheter-based imaging of these regions to assess
plaque and calcification morphology. In this way,
clinicians may be able to implement the size and
FIGURE 2. Matrix vesicles and microcalcifications in atherosclerotic plaques. (a) Transmission electron microscopy image of
matrix vesicles aggregating within a plaque in close proximity to ChC. An AB is shown for size comparison. (b) Transmission
electron microscopy of aggregating matrix vesicles nucleating mineralization. (c) NIRF staining of microcalcifications within a
mouse plaque. (d) NIRF staining of microcalcifications at the plaque border. AB, apoptotic body; ChC, cholesterol crystals;
NIRF, near-infrared fluorescent. Reproduced with permission from [26
&&].
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morphology criteria established by biomechanical
modeling to make informed treatment decisions.
In addition to the advent of promising tech-
niques to identify vulnerable plaques in situ, fluor-
escent probes already in use offer the resolution to
identify microcalcifications in preclinical animal
models and pathological analyses of resected tissues
(Fig. 2c, d). Near-infrared fluorescent (NIRF) probes
for hydroxyapatite, the calcium phosphate-based
mineral involved in calcification, allow earlier
detection of calcification in human plaques than
light microscopy techniques currently used by
pathologists [41]. These tracers are based on the
conjugation of a NIRF moiety attached to a
bisphosphonate backbone. Bisphosphonates have
a similar structure to pyrophosphate, irreversibly
bind calcium and accumulate in regions of
calcium-based mineralization. NIRF tracers have
been successfully used in intravital microscopy to
detect vascular calcification in mice [41–43]; there-
fore, this technique can be utilized to monitor
the progression of calcification in longitudinal
animal studies and diagnose microcalcifications
on histological sections. This enhanced resolution
due to NIRF signal amplification may allow
researchers to understand the nucleation of micro-
calcifications and allow pathologists to readily
identify the presence of microcalcifications in
subclinical atherosclerotic plaques. The formation
of calcified plaques may also give insight into the
nucleation and aggregation mechanisms that lead
to large calcifications.
CONCLUSION
Emerging evidence suggests that microcalcifications
play a critical role in determining atherosclerotic
plaque vulnerability (Fig. 3). Model-based bio-
mechanical analyses of plaques indicate that the
size, morphology, size and location of calcification
within the plaque are more important indicators of
plaque stability than the presence of calcification
solely. The presence of small microcalcifications
within the fibrous cap of the plaque can greatly
increase the amount of stress in the cap. When this
stress exceeds the threshold required for cap failure,
the plaque ruptures, leading to thrombus formation
and vessel occlusion. The rupture of asymptomatic
plaques and vessel occlusion are silent contributors
to sudden stroke and myocardial infarction, the
leading causes of cardiovascular morbidity and
mortality. Studies suggest that vascular calcifica-
tions form as part of an active process wherein
cellular-derived vesicles within the plaque serve as
nucleating foci for the formation of calcium phos-
phate mineral. This active mechanism provides
hope that therapeutic strategies may be developed
to target dangerous microcalcifications. As future
studies progress our understanding of the nucleat-
ing events of mineralization, the development of
preventive strategies for calcification or therapeutic
interventions that may reduce calcification or shift
it to a more favorable phenotype may be within
reach.
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